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Introduction: This is the first published report of a young girl with co-inherited sickle cell-β+ thalassemia and cystic
fibrosis. Although a small subset of patients with co-inherited cystic fibrosis and other hemoglobinopathies have
been reported, this patient developed early hematologic and pulmonary complications that were more severe than
the previous cases. To assess pulmonary co-morbidities, we used infant pulmonary function testing through the
raised volume rapid thoracoabdominal compression technique as both an established study of early cystic fibrosis
and also as a newer study of mechanism for early sickle cell lung disease. This further serves as the first report of
the raised volume rapid thoracoabdominal compression technique to determine raised volume forced expiratory
flows and fractional lung volumes in a patient with a hemoglobinopathy.
Case presentation: A 2-year-old African-American girl with co-inherited cystic fibrosis and sickle cell-β+ thalassemia
developed severe hematologic complications (recurrent vaso-occlusive events, hepatic sequestration, and acute
chest syndrome) during periods of cystic fibrosis pulmonary exacerbations and weight loss. Because cystic fibrosis
and sickle cell-β+ thalassemia both confer distinct patterns of pulmonary disease, infant pulmonary function testing
with the raised volume rapid thoracoabdominal compression technique was used to define respiratory
pathophysiology and guide treatment options. Infant pulmonary function testing data demonstrated moderate-to-
severe lower airways obstruction, moderate air trapping, and no evidence of restrictive lung disease.
Conclusions: Infant pulmonary function testing with the raised volume rapid thoracoabdominal compression
technique guided therapy in this patient with cystic fibrosis and sickle cell-β+ thalassemia. Although this is an
original case report on a unique patient, this case highlights the need to evaluate early respiratory
pathophysiology in a broader population of young patients with hemoglobinopathies and screen those at risk for
early pulmonary co-morbidities.
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Cystic fibrosis (CF) and sickle cell-β+ thalassemia (S-βthal)
are both autosomal recessive conditions with associated
acute and chronic pulmonary morbidities such as acute
chest syndrome (ACS), sickle chronic lung disease (SCLD),
and CF-related bronchiectasis. Multiple early interventions
have been instituted in an attempt to reduce the incidence
and severity of respiratory complications associated with
SCLD and CF that often start in infancy. These have in-
cluded newborn screening programs for CF and hemoglo-
binopathies along with referral to subspecialty physicians
and established care programs focused on minimizing
anticipated complications. In recent years, infant pul-
monary function testing (IPFT) using the raised volume
rapid thoracoabdominal compression (RVRTC) technique
has been applied as a clinical tool and research aid to as-
sess early airway obstruction and air trapping in infants
with CF [1] and in infants with cough or wheeze unre-
sponsive to bronchodilators [2]. There are no published
data on infants with sickle cell disease (SCD) using the
RVRTC technique and there is only one study detailing
lung function measures in infants with SCD using a
partial raised volume technique with findings suggestive
of lower airways obstruction [3]. The advantage of the
RVRTC technique over either partial expiratory flow or
tidal breathing maneuvers is that flows are assessed
over much larger lung volumes and there is achievement
of flow limitation. Thus, the measures are more likely
to be effort-independent; thereby reflecting underlying
lung mechanics [4].
We present a novel case of a young girl with co-
inherited CF and S-βthal. This patient developed multiple
CF pulmonary exacerbations (defined for this patient by
fever presence, increased cough, new infiltrate on chest
radiograph, and initiation of intravenous antibiotics) and
ACS (defined by the presence of rapid onset of fever,
hypoxia, new infiltrate on chest radiograph, and any re-
spiratory symptoms). IPFT measures using the RVRTC
technique were obtained to help define her respiratory
pathophysiology. This is the first known report of raised
volume forced expiratory flow measures and fractional
lung volumes in a young child with CF and a hemoglo-
binopathy. We will highlight considerations for manage-
ment in this rare population and how this was guided,
in part, by infant lung function testing.
Case presentation
A 17-day-old African-American girl was admitted for man-
agement of failure to thrive and general malaise. The initial
workup was guided, in part, by an abnormal newborn
hemoglobin electrophoresis screen consistent with SCD.
Repeat electrophoresis confirmed a diagnosis of S-βthal.
In addition to the patient’s hematologic workup, the
patient was found to have a severely low fecal elastaselevel (<50μg elastase/g stool) consistent with pancreatic
insufficiency. Subsequent sweat testing was performed
and was positive on two occasions (73 and 72mmol/L
with first test; 88 and 103mmol/L with second test)
confirming a diagnosis of CF. CF genotyping results were
positive for one intronic mutation for C.53+2 T>C; a
second mutation was not identified.
This patient, who is now 4 years of age, has required
15 hospitalizations (most during the first 2 years of life)
to manage complications of both CF and S-βthal. In gen-
eral, the majority of hospitalizations were for presumed
CF pulmonary exacerbations or weight loss. At 2 years
of age, the patient began to develop vaso-occlusive events
(VOE) including multiple bouts of pain crises and hepatic
sequestration contributing to prolonged hospital stays
for CF pulmonary exacerbations. Pain crises involving
the chest, back, and abdomen limited both airway clearance
and nutritional support with enteral feedings. Furthermore,
the patient faced acute respiratory decline during VOE
with hypoxia, fever, wheezing, and a new pulmonary
infiltrate on chest radiograph consistent with ACS. The
underlying etiology of ACS development was unclear
although it was attributed to complications of CF, S-βthal,
or both. Along with computed tomography imaging of
the chest (mild bronchiectasis with bibasilar opacities
consistent with atelectasis) and flexible bronchoscopy
(normal airway anatomy with diffuse, viscous white secre-
tions with 2,704 cells/mm3 and 51% neutrophils), IPFT
measures were obtained to better define respiratory physi-
ology and guide a treatment plan.
Infant lung function testing was performed using the
RVRTC technique which elevates the lung volume of in-
fants to near total lung capacity prior to performing a
rapid thoracic compression maneuver. These forced ex-
piratory flows from raised lung volumes were obtained
after sedation with chloral hydrate according to American
Thoracic Society/European Respiratory Society guidelines
and approximate adult-type lung function maneuvers [5].
Post-bronchodilator results were not obtained due to
lack of sedative effects near the end of testing. IPFT data
(Figure 1A) demonstrate moderate-to-severe lower air-
ways obstruction, moderate air trapping, and no evidence
of restrictive lung disease.
The IPFT data prompted initiation of inhaled deoxy-
ribonuclease (DNase) in an effort to reduce any distal neu-
trophilic mucus impaction contributing to air trapping.
In addition, due to the combination of frequent VOE,
ACS, and new evidence of lower airways obstruction,
hydroxyurea was started to attempt to theoretically minimize
progression of SCLD [7]. Although hydroxyurea is pre-
dominantly utilized in patients with more severe forms
of SCD, clinical response has been shown in patients
with S-βthal [8]. Chronic transfusion therapy was consid-
ered but is not optimal given the risks of iron overload,
FVC 88% of predicted
FEV0.5 86% of predicted
FEV0.5 / FVC 0.68
FEF25-75 74% of predicted
FEF75 42% of predicted
FEF85 35% of predicted
TLC 1.13 Liters 109% of predicted
FVC 0.68 Liters 83% of predicted
FRC 0.57 Liters 162% of predicted
RV 0.45 Liters 203% of predicted
RV/TLC 0.40 185% of predicted
FVC 109% of predicted
FEV1 84% of predicted
FEV1/FVC 0.68
FEF25-75 58% of predicted
TLC 1.94 Liters 155% of predicted
VC 1.15 Liters 119% of predicted
FRC 1.16 Liters 205% of predicted
































Figure 1 Pulmonary function testing data. A. Acquired at 2 years of age using the raised volume rapid thoracoabdominal compression
technique along with whole body plethysmography. Normative data by Castile et al. and Jones et al. [4,6]. B. Acquired at 4 years of age using
classical spirometry and whole body plethysmography. FVC- Forced vital capacity; FEV0.5 - Forced expiratory volume in 0.5 second; FEF25-75 - Forced
expiratory flow between 25 and 75% of the FVC; FEF75 - Forced expiratory flow at 75% of the FVC; FEF85 - Forced expiratory flow at 85% of the FVC;
TLC- Total lung capacity; FRC- Functional residual capacity; RV- Residual volume; FEV1 – Forced expiratory volume in 1 second; VC- Vital capacity.
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kocyte antigen sensitization that could complicate future
stem cell and/or lung transplantation. Hospitalization fre-
quency has subsequently improved with a reduction from
3.5 admissions/year to 0.5 admission/year following IPFT
and therapeutic interventions. Spirometry data obtained
at 4 years of age is included for comparison in Figure 1B.
Although expiratory time is short, flow-volume loops re-
flect evidence of effort-independent flow limitation and
suggest continued moderate lower airways obstruction with
significant response to bronchodilator. Inhaled budesonide
was initiated following spirometry secondary to the findings
of bronchodilator responsiveness.
Discussion
To the best of our knowledge, this is the first reported
case of a patient with co-inherited CF and S-βthal. Only
four previous case reports have described a subset of five
patients with co-inherited CF and a hemoglobinopathy
(Table 1) [9-12]. In the previous cases, lung function
remained relatively well preserved. Furthermore, pulmon-
ary and hematologic complications were not concurrent.
By contrast, the patient in this case report showed signifi-
cant loss of lung function at an early age as demonstrated
by IPFT. In addition, CF pulmonary exacerbations fre-
quently occurred in temporal association with ACS and
pain crises.The rationale for concurrent pulmonary and hematologic
complications is probably multifactorial and may be ex-
plained due to a combination of pathophysiologic effects.
Intraluminal airway secretions are known to have different
cellularity in CF bacteriologic bronchitis compared to plas-
tic bronchitis associated with ACS. If airway secretions are
available from sputum collection or bronchoalveolar lavage,
formal pathologic assessment may guide therapeutic op-
tions based upon cellular and/or fibrinous appearance. In
addition, in vitro assessment of airway secretions exposed
to different therapeutic modalities may help guide therapy.
DNase has been shown in both CF and ACS to aid in air-
way clearance [13-15]. Additional small case reports have
evaluated the potential utility of inhaled N-acetylcysteine
[14,16], along with inhaled tissue plasminogen activator
[17] although data is sparse with these therapeutic options.
The patient in this report was unable to provide expecto-
rated sputum samples due to her age. Bronchoalveolar
lavage fluid was not obtained during acute pulmonary
exacerbations secondary to concerns for worsening atelec-
tasis and escalating oxygen needs after general anesthesia.
Regardless of the cellular makeup of the intraluminal se-
cretions, it is probable that either would cause regional
changes in oxygenation, both of which could precipitate
the development of ACS.
Another complicating factor was the need for high dose
opioid narcotics during pain crises. Opioid narcotics may
able 1 Current and prior case reports of co-inherited cystic fibrosis and sickle cell disease
eference Cystic fibrosis genotype Cystic fibrosis complications Hemoglobin disease classification Hematologic complications Co-morbid conditions
orter et al. [9] Unknown -Meconium ileus Hemoglobin SS -Acute transfusions -None reported
orter et al. [9] Unknown -Recurrent bronchitis Hemoglobin SS -Anemia -None reported
mendola et al. [10] Unknown -Recurrent bronchitis Hemoglobin SD -Chronic transfusions -None reported
-Pancreatic insufficiency
arwick et al. [11] Unknown -Recurrent bronchitis Hemoglobin SS -Bone pain -Cardiomegaly
-Pancreatic insufficiency
anjar [12] H549L/S549R -Sinusitis Hemoglobin SS -Bone pain -Obstructive sleep apnea
-Recurrent bronchitis -Chronic transfusions -Hypercalciuria
-Pancreatic insufficiency -Gastroesophageal reflux
urrent case C53+2T>C/Unknown -Recurrent bronchitis Hemoglobin-β+ thalassemia -Bone pain -Gastroesophageal reflux
-Failure to thrive -Abdominal sequestration -Nissen fundoplication
-Burkholderia cepacia -Acute chest syndrome -Gastrostomy tube
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may contribute to airway hyperresponsiveness or increased
airway edema. Use of aggressive narcotics for pain to allow
airway clearance was favored over the possibility of wors-
ened lower airways obstruction due to a direct opioid effect.
Analgesic alternatives including intravenous ketorolac and
transdermal lidocaine were utilized in the interest of min-
imizing opioid dosing.
The approach to managing an acute respiratory de-
cline proved difficult in this patient due to the multiple
disease processes involved. IPFT was utilized to help de-
lineate various possible pathophysiologic mechanisms:
lower airways obstruction, regional air trapping, and/or
restrictive lung disease. Children with SCD are more
likely to have wheezing and symptoms of airway hyper-
responsiveness during episodes of ACS and have a
higher incidence of asthma than the general population.
Data supports an association between asthma and in-
creased frequency of ACS in older patients with SCD
however the temporal relationship has not been defined
[18]. As these patients age, they often develop SCLD, a
restrictive lung disorder as evidenced by adult pulmonary
function data [19]. With the multiple episodes of ACS in
this case, there was an unexpected lack of restrictive
lung disease according to the IPFT data. Data are lack-
ing regarding the incidence and severity of lung disease
in young children with SCD. A multicenter clinical trial
addressing this question would be of immense value to
the sickle cell population and the clinical teams caring
for these children.
Conclusions
Although the co-inheritance of CF and a hemoglobinopathy
is relatively rare, the use of infant lung function testing
as detailed in this report may be of benefit to a broader
population of young children with SCD. With the ad-
vanced technology allowed by the RVRTC technique,
young patients with SCD may have their lung function
followed longitudinally. Should this population have evi-
dence of early lung disease, IPFT could become an add-
itional screening tool to allow for earlier interventions
that could minimize the progression of chronic lung
disease in SCD.
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